Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Surg. cosmet. dermatol. (Impr.) ; 13: e20210021, jan.-dez. 2021.
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1368732

ABSTRACT

Introdução: O status do linfonodo sentinela (LNS) tem se mostrado o mais importante fator prognóstico independente no melanoma cutâneo (MC) em estágio I-II. Poucos artigos sobre MC em clínicas privadas (CP) estão disponíveis. Objetivo: Apresentar dados clínicos e histológicos, complicações e frequência de envolvimento do LS em pacientes com MC acompanhados em CP de dermatologia/oncologia cutânea em São Paulo/Brasil, submetidos a biópsia de LS (BLNS). Métodos: Coorte retrospectiva e unicêntrica de pacientes atendidos em CP de junho/1998 a janeiro/2020. Prontuários eletrônicos foram analisados. O período mínimo para considerar paciente elegível foi de um ano. Resultados: Identificamos 215 MC em 184 pacientes (1,2 melanoma/paciente). No total, 47 pacientes (25,5%) foram submetidos à BLNS e 59 LN à exame histológico (1,2 LNS/paciente), sendo que 10,9% foram positivo. A identificação do LNS ocorreu em 95,7%. Dezoito (72,0%) das 25 lesões do tronco drenavam para cadeias únicas, enquanto em 7 pacientes drenavam para cadeias múltiplas. A taxa de complicação foi de 6,0%. Conclusão: O percentual de pacientes com MC submetidos a BLNS, positividade de LS, cadeias de drenagem e complicações neste estudo foram semelhantes aos estudos em pacientes do hemisfério norte. As características clínicas e epidemiológicas dos pacientes com MC diferem acentuadamente entre os pacientes de CP e do serviço público de saúde.


Background: Sentinel Lymph Node (SLN) status has been shown to be the strongest independent prognostic factor of cutaneous melanoma (CM) stage I-II patients. Few papers on CM at private clinics (PC) are available. Objective: To present clinical and histologic data, complications and frequency of SLN involvement in CM patients diagnosed and followed at a dermatology/cutaneous oncology PC in São Paulo/Brazil, who were submitted to SLNB. Methods: Retrospective, single-center cohort of patients who attended PC from June 1998 to Jan 2020. Electronic files were selected and analyzed. Minimum period for considering the patient eligible was 1 year. Results: 215 CM lesions were identified in 184 patients(1.2 melanoma/patient). Forty-seven patients (25.5%) were submitted to SLNB and 59 SLN for histologic examination (1.2 SLN/patient). 10,9% tested positive. SLN identification happened in 95.7%. In 38/47 (80,8%) patients single LBD was found, while multiple-LBD was found in 9/47(19.1%). Eighteen(72,0%) out of 25 trunk lesions drained to single basins, while in 7 patients multiple LBD was found. Complication rate was 6,0%. Conclusion: Percentage of CM patients that undergo SLNB, node positivity for metastasis, draining basins and complications in this study were similar to studies in northern hemisphere patients. Clinical and epidemiologic characteristics of CM patients differ markedly between PC and PHS patients.

2.
An. bras. dermatol ; 93(3): 337-340, May-June 2018. tab
Article in English | LILACS | ID: biblio-949897

ABSTRACT

Abstract: BACKGROUND: Approximately five to 10% of all melanomas occur in families with hereditary predisposition and the main high-risk melanoma susceptibility gene is the CDKN2A. OBJECTIVES: To describe, after a five-years study, the clinical data of patients (probands) from familial melanoma kindreds, and the pathological characteristics of their melanoma. METHODS: The inclusion criteria were melanoma patients with a family history of melanoma or pancreatic cancer (first- or second-degree relatives) or patients with multiple primary melanomas (MPM). RESULTS: A total of 124 probands were studied, where 64 were considered familial cases and 60 MPM. Mean age at diagnosis was 50 years. Our results show that the following characteristics were prevalent: skin phototype I/II (89.5%), sunburn during childhood (85.5%), total number of nevi ≥50 (56.5%), Breslow thickness ≤1.0mm (70.2%), tumors located on the trunk (53.2%) and superficial spreading melanomas (70.2%). STUDY LIMITATIONS: Analyses of probands' relatives will be demonstrated in future publication. CONCLUSIONS: Our findings are in agreement with previous familial melanomas reports. Fifteen new melanomas in 11 patients were diagnosed during follow up, all of which were ≤1.0 mm. This is the largest dataset of Brazilian melanoma prone kindreds to date, thus providing a complete database for future genetic studies.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Phenotype , Skin Neoplasms/genetics , Melanoma/genetics , Skin Neoplasms/pathology , Brazil , Family Health , Risk Factors , Inheritance Patterns , Melanoma/pathology
3.
Appl. cancer res ; 37: 1-5, 2017. tab, ilus
Article in English | LILACS, Inca | ID: biblio-914894

ABSTRACT

Background: Cutaneous melanoma (CM) is the most aggressive subtype of skin cancer, with increasing incidence over the past several decades. DNA methylation is a key element of several biological processes such as genomic imprinting, cell differentiation and senescence, and deregulation of this mechanism has been implicated in several diseases, including cancer. In order to understand the relationship of DNA methylation in CMs, we searched for an epigenetic signature of cutaneous melanomas by comparing the DNA methylation profiles between tumours and benign melanocytes, the precursor cells of CM. Methods: We used 20 primary CMs and three primary cell cultures of melanocytes as a discovery cohort. The tumours mutational background was collected as previously reported. Methylomes were obtained using the HM450K DNA methylation assay, and differential methylation analysis was performed. DNA methylation data of CMs from TCGA were recovered to validate our findings. Results: A signature of 514 differentially methylated genes (DMGs) was evident in CMs compared to melanocytes, which was independent of the presence of driver mutations. Pathway analysis of this CM signature revealed an enrichment of proteins involved in the binding of DNA regulatory regions (hypermethylated sites), and related to transmembrane signal transducer activities (hypomethylated sites). The methylation signature was validated in an independent dataset of primary CMs, as well as in lymph node and distant metastases (correlation of DNA methylation level: r > 0,95; Pearson's test: p < 2.2e-16). Conclusions: CMs exhibited a DMGs signature, which was independent of the mutational background and possibly established prior to genetic alterations. This signature provides important insights into how epigenetic deregulation contributes to melanomagenesis in general (AU)


Subject(s)
Humans , Male , Female , Skin Neoplasms , Signal Transduction , DNA Methylation , DNA-Binding Proteins , Transcriptome/genetics , Melanoma
4.
Clinics ; 66(10): 1817-1823, 2011. tab
Article in English | LILACS | ID: lil-601919

ABSTRACT

Merkel cell carcinoma is a very rare and aggressive neoplasm. Due to its rarity, therapeutic guidelines are not well established, especially for regionally advanced disease. Articles in English, French, Italian, Portuguese, and Spanish from the last 20 years were identified in MEDLINE and reviewed. The key word "Merkel" was used for the search, relevant articles were selected, and their references were examined. The most important articles related to epidemiology, genesis and treatment were reviewed. The incidence of Merkel cell carcinoma is increasing due to the advancing age of the population, higher rates of sun exposure and an increasing number of immunocompromised individuals. With regard to etiology, the recently described Merkel Cell polyomavirus is thought to play a role. Either local or regional surgical intervention remains the standard of care, but adjuvant radiotherapy or radiotherapy as a primary treatment have been discussed as reasonable therapeutic options. An update on this rare neoplasia is essential because of its increasing incidence and changing treatment options.


Subject(s)
Humans , Carcinoma, Merkel Cell , Skin Neoplasms , Carcinoma, Merkel Cell/epidemiology , Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/therapy , Neoplasm Staging , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Skin Neoplasms/therapy
5.
An. bras. dermatol ; 85(6): 863-871, nov.-dez. 2010. ilus, tab
Article in Portuguese | LILACS | ID: lil-573626

ABSTRACT

O nevo atípico (displásico) é considerado um fator importante associado com o risco aumentado de desenvolvimento do melanoma cutâneo. Acredita-se que nevos atípicos sejam lesões precursoras do melanoma cutâneo. Podem estar presentes em pacientes com múltiplos nevos melanocíticos (síndrome do nevo atípico) ou isolados e em poucas quantidades em um contexto não familial. Aparecem, geralmente, na puberdade e prevalecem em indivíduos jovens. Têm predileção por áreas expostas ao sol, especialmente, o tronco. O grande desafio em relação ao nevo atípico reside na controvérsia em se definir sua nomenclatura, diagnóstico clínico, critérios dermatoscópicos, diagnóstico histopatológico e aspectos moleculares. Esta revisão tem por objetivo trazer o conhecimento, facilitar o entendimento e responder às questões duvidosas concernentes ao nevo atípico.


Atypical nevum (dysplastic) is considered an important factor associated with increased risk of developing cutaneous melanoma. It is believed that atypical nevi are precursor lesions of cutaneous melanoma. They may be present in patients with multiple melanocytic nevi (atypical nevus syndrome) or isolated and in small numbers in a non-familial context. The disease usually begins at puberty and predominates in young people. It has a predilection for sun-exposed areas, especially the trunk. The major challenge in relation to atypical nevi lies in the controversy of defining its nomenclature, clinical diagnosis, dermoscopic criteria, histopathological diagnosis and molecular aspects. This review aims at bringing knowledge, facilitating comprehension and clarifying doubts about atypical nevus.


Subject(s)
Humans , Dysplastic Nevus Syndrome/pathology , Melanoma/pathology , Precancerous Conditions/pathology , Skin Neoplasms/pathology , Dermoscopy , Diagnosis, Differential , Dysplastic Nevus Syndrome/epidemiology , Precancerous Conditions/epidemiology , Skin Neoplasms/epidemiology
6.
São Paulo med. j ; 128(1): 38-41, Jan. 2010. tab
Article in English | LILACS | ID: lil-547392

ABSTRACT

CONTEXT AND OBJECTIVE: Vulvar melanoma is a rare disease. We describe the experience of a single institution and review the literature. DESIGN AND SETTING: Retrospective study at the Department of Gynecology, Hospital do Cancer A. C. Camargo. METHODS: Eleven patients with vulvar melanoma attended between January 1987 and December 2006 were reviewed regarding clinicopathological characteristics, surgical therapy and follow-up. RESULTS: The initial symptoms were vulvar lesions, pruritus, pain and bleeding. The median age was 64.8 years. The median depth of invasion was 3.08 mm. The staging ranged from IB to IIIC (American Joint Committee on Cancer, 2002). All the patients underwent vulvectomy. Two patients did not undergo primary elective lymphadenectomy. Bilateral inguinal lymphadenectomy was performed on five patients, and one had unilateral inguinal lymphadenectomy. Sentinel lymph node investigation was performed on three patients. Five patients had locoregional recurrence. Prolonged survival was only achieved in the absence of lymph node involvement. The median follow-up was 56 months. The median disease-free survival was 15 months and the median overall survival was 29 months. CONCLUSIONS: The prognosis for patients with vulvar melanoma is generally poor, with a high tendency towards regional and distant recurrence. Depth of invasion and lymph node involvement are the most important prognostic factors. In most cases, resection of the lesion with adequate margins may replace vulvectomy. Elective inguinal femoral lymphadenectomy remains the standard lymph node staging procedure. Sentinel lymph node investigation is feasible and should be performed by a multidisciplinary team with experience of this method.


CONTEXTO E OBJETIVO: Melanoma de vulva é uma doença rara. Descrevemos a experiência de uma instituição e revisamos a literatura. TIPO DE ESTUDO E LOCAL: Estudo retrospectivo no Departamento de Ginecologia do Hospital do Câncer A. C. Camargo. MÉTODOS: De Janeiro de 1987 a Dezembro de 2006, foram revisados aspectos clínico-patológicos, tratamento cirúrgico e acompanhamento de 11 pacientes com melanoma de vulva. RESULTADOS: Lesão vulvar, prurido, dor e sangramento foram sintomas iniciais. A idade mediana foi 64,8 anos. A mediana da profundidade de invasão foi 3.08 mm. O estadiamento variou de IB a IIIC (American Joint Committee on Cancer, 2002). Todas as pacientes foram submetidas a vulvectomia. Duas pacientes não foram submetidas a linfadenectomia eletiva primária. A linfadenectomia inguinal bilateral foi realizada em cinco pacientes e uma foi submetida à linfadenectomia inguinal unilateral. A pesquisa do linfonodo sentinela foi realizada em três casos. Cinco tiveram recidiva locorregional. A sobrevida prolongada esteve relacionada com a ausência de comprometimento linfonodal. O tempo mediano de acompanhamento foi de 56 meses. A sobrevida mediana livre de doença foi de 15 meses e a sobrevida mediana global de 29 meses. CONCLUSÕES: O prognóstico das pacientes com melanoma de vulva geralmente é ruim, com tendência a recorrência regional e à distância. A profundidade de invasão e envolvimento linfonodal são os principais fatores prognósticos. Na maioria dos casos a ressecção da lesão com margens adequadas pode substituir a vulvectomia. A linfadenectomia inguino-femoral eletiva ainda é o procedimento padrão para estadiamento linfonodal. Pesquisa do linfonodo sentinela é factível e deve ser realizada por equipe multidisciplinar com experiência no método.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Middle Aged , Melanoma/surgery , Vulvar Neoplasms/surgery , Follow-Up Studies , Lymph Node Excision , Melanoma/pathology , Neoplasm Staging , Prognosis , Retrospective Studies , Sentinel Lymph Node Biopsy , Survival Rate , Vulvar Neoplasms/pathology
7.
An. bras. dermatol ; 80(5): 499-502, set.-out. 2005. ilus
Article in Portuguese | LILACS | ID: lil-418792

ABSTRACT

Os principais méritos da biópsia de linfonodo sentinela em pacientes com melanoma cutâneo residem na possibilidade de serem evitadas linfadenectomias radicais desnecessárias e de permitir a correta identificação da cadeia de drenagem linfática, principalmente quando o tumor se localiza em áreas de drenagem ambígua. Atualmente já foi incorporada como fator prognóstico, sendo importante dado para o correto estadiamento do paciente. No presente relato são apresentados dois casos em que a utilização desta técnica foi extremamente útil, sobretudo por ter identificado a presença de drenagem linfática para duas cadeias linfáticas distintas. é importante que o dermatologista esteja consciente da correta indicação da técnica, para poder orientar da melhor forma possível seus pacientes.


Subject(s)
Humans , Melanoma , Radionuclide Imaging , Sentinel Lymph Node Biopsy , Skin Neoplasms
8.
Arq. bras. oftalmol ; 68(1): 21-27, jan.-fev. 2005. tab
Article in Portuguese | LILACS | ID: lil-396351

ABSTRACT

OBJETIVO: Analisar a freqüência e a etiologia das doenças oculares micóticas diagnosticadas por cultura no Laboratório de Doenças Externas Oculares da Universidade Federal de São Paulo (LOFT-UNIFESP), São Paulo, SP, Brasil e os fatores associados às ceratites fúngicas. MÉTODOS: Estudo retrospectivo de 14.391 solicitações de exames laboratoriais de doenças infecciosas oculares no período compreendido entre 1975 e maio de 2003. Nas comprovações por cultura de micoses oculares foram observados o tipo morfológico do fungo isolado, o sexo e a idade dos pacientes, o local de acometimento da infecção ocular, os anos de identificação e os fatores associados nos casos de ceratite fúngica, conforme o agente etiológico identificado. Considerou-se significante p<0,05. RESULTADOS: Foram verificadas 296 (2,05 por cento) comprovações por cultura de infecção ocular micótica, sendo 265 (89,5 por cento) identificadas como agente etiológico de ceratites, 27 de infecções intra-oculares (9,1 por cento) e 4 de outros locais (1,3 por cento). Fungos filamentosos foram identificados em 233 casos (78,7 por cento), sendo 74,7 por cento dos pacientes do sexo masculino (n=174) e 25,3 por cento do sexo feminino (n=59). Em 63 exames (21,3 por cento) foram isolados fungos leveduriformes, sendo 49,2 por cento dos casos do sexo masculino (n=31) e 50,8 por cento do sexo feminino (n=32).As idades variaram entre 2 e 99 anos no grupo dos fungos filamentosos e entre 14 e 88 anos no grupo dos fungos leveduriformes. Os fungos filamentosos mais freqüentemente encontrados foram Fusarium (n=137 ou 58,8 por cento), Aspergillus (n=28 ou 12,0 por cento) e Penicillium (n=12 ou 5,2 por cento). Entre as leveduras, o gênero mais freqüente foi a Candida (n=59 ou 93,7 por cento). Em relação às ceratites, 95,1 por cento das solicitações apresentadas tiveram pelo menos um fator associado. Trauma ocular foi significativamente associado às ceratites por fungos filamentosos (p=0,0002); e, cirurgias (p=0,0002), doenças oculares prévias (p=0,0002) e sistêmicas (p=0,0002) às infecções por fungos leveduriformes. O uso de antibióticos tópicos mostrou associação com infecção por fungos filamentosos, com menor significância estatística (p=0,0224). CONCLUSÕES: A análise laboratorial mostrou predomínio de infecções por fungos filamentosos sobre os leveduriformes, destacando-se a ceratite micótica como a principal doença verificada. A maioria das ceratites fúngicas apresentou pelo menos um fator associado.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Keratitis/etiology , Keratitis/microbiology , Eye Infections, Fungal/complications , Eye Infections, Fungal/epidemiology , Eye Infections, Fungal/microbiology , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL